Notably, in CC4, we observed co‐localisation of ILC2s with cells associated with tertiary lymphoid structures (TLS), including CD4+ Tfh cells, B‐CD40‐GC‐like cells and tumour cells (Figure 5E). The gene discussed is CD4; the disease is neoplasm.